R C Petersen1, R Doody, A Kurz
1Department of Neurology, Mayo Clinic Rochester, 200 First St SW, Rochester, MN 55905, USA. peter8@mayo.edu
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Mild cognitive impairment (MCI) is a transitional stage between normal aging and Alzheimer's disease (AD). Individuals with MCI show accelerated progression to AD, making it a key focus for early therapeutic interventions.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: